{"id":330280,"date":"2025-10-24T23:45:15","date_gmt":"2025-10-24T23:45:15","guid":{"rendered":"https:\/\/www.europesays.com\/us\/330280\/"},"modified":"2025-10-24T23:45:15","modified_gmt":"2025-10-24T23:45:15","slug":"over-140000-bottles-of-popular-cholesterol-drug-atorvastatin-recalled-by-fda","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/330280\/","title":{"rendered":"Over 140,000 bottles of popular cholesterol drug Atorvastatin recalled by FDA"},"content":{"rendered":"<p>Federal health officials are advising consumers that more than 140,000 bottles of cholesterol medication are being recalled due to \u201cfailed dissolution specifications.\u201d<\/p>\n<p>Several bottle sizes of Atorvastatin Calcium Tablets, 10-mg (Prescription Only), a medicine used to lower cholesterol and help prevent heart disease, heart attacks and strokes, are impacted by the recall, <a href=\"https:\/\/nypost.com\/2025\/10\/15\/business\/fda-recalls-16-cinnamon-brands-with-elevated-lead-levels-heres-what-to-know\/\" target=\"_blank\" rel=\"noopener\">the Food and Drug Administration<\/a> (FDA) said in an enforcement report.<\/p>\n<p>Atorvastatin Calcium Tablets are the generic form of Lipitor and is a medicine from a group called statins. It works by blocking an enzyme in the liver that the body uses to make cholesterol.<\/p>\n<p>If a medication has \u201cfailed dissolution specifications,\u201d it means the drug did not dissolve in laboratory testing the way it is supposed to according to official standards. <\/p>\n<p>If a pill doesn\u2019t dissolve the way it should, the medicine might not work as effectively to control cholesterol levels.<\/p>\n<p>The alert is considered a Class II recall, which is when the use or exposure to a product \u201cmay cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,\u201d according to the FDA\u2019s website.<\/p>\n<p><img loading=\"lazy\" style=\"aspect-ratio:1.49926794;display:block\" decoding=\"async\" data-modal-image=\"37477270\" width=\"885\" height=\"590\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/10\/undated-photo-provided-watson-pharmaceuticals-39315035.jpg\" alt=\"Bottle of Atorvastatin Calcium 80 mg tablets.\" class=\"wp-image-37477270\"  \/>Atorvastatin Calcium Tablets are the generic form of Lipitor and is a medicine from a group called statins. AP<\/p>\n<p><img loading=\"lazy\" style=\"aspect-ratio:2.33257403;display:block\" decoding=\"async\" data-modal-image=\"37477269\" width=\"1024\" height=\"439\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/10\/closeup-pharmacist-s-hands-dispensing-114116525.jpg\" alt=\"A pharmacist dispensing white pills from a bottle into their hand.\" class=\"wp-image-37477269\"  \/>The FDA said that 10-mg prescription only bottles of Atorvastatin Calcium Tablets are impacted. narak0rn \u2013 stock.adobe.com<\/p>\n<p>The medication was manufactured by Alkem Laboratories and distributed by Ascend Laboratories LLC.<\/p>\n<p>There are eight lot numbers impacted with expiration dates ranging between July 2026 to February 2027. <\/p>\n<p>\t\t\t\t\t\t\tStart your day with all you need to know\t\t\t\t\t\t<\/p>\n<p class=\"inline-module__cta\">\n\t\t\t\t\t\t\tMorning Report delivers the latest news, videos, photos and more.\t\t\t\t\t\t<\/p>\n<p>\t\t\t\t\t\tThanks for signing up!\n\t\t\t\t<\/p>\n<p>The bottle sizes included 90 tablets, 500 tablets and 1,000 tablets.<\/p>\n<\/p>\n<p>FOX Business reached out to Alkem Laboratories and Ascend Laboratories for comment.<\/p>\n","protected":false},"excerpt":{"rendered":"Federal health officials are advising consumers that more than 140,000 bottles of cholesterol medication are being recalled due&hellip;\n","protected":false},"author":3,"featured_media":330281,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[64,151,210,1060,11825,12310,67,132,68],"class_list":{"0":"post-330280","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-business","9":"tag-fda","10":"tag-health","11":"tag-medication","12":"tag-prescription-drugs","13":"tag-recalls","14":"tag-united-states","15":"tag-unitedstates","16":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115431809455284413","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/330280","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=330280"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/330280\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/330281"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=330280"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=330280"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=330280"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}